Moderna (MRNA) IV into BARDA additional $472M commitment

Moderna (NASDAQ: MRNA) Moderna (NASDAQ: MRNA) July weekly call option implied volatility is at 97, August is at 102; compared to its 52-week range of 51 to 172 into Biomedical Advanced Research and Development Authority, or BARDA, making an additional commitment of up to $472M to support late stage clinical development including the expanded Phase 3 study of the company's mRNA vaccine candidate against COVID-19.

You May Also Be Interested In

• StubHub (STUB) call put ratio 2.7 calls to 1 put
• Baidu (BIDU) call put ratio 1.5 calls to 1 put
• Hallador Energy (HNRG) call put ratio 2.7 calls to 1 put with a focus on January 10 puts and January 20 calls